Skip to main content
. Author manuscript; available in PMC: 2014 Oct 10.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Jul 24;22(10):1747–1755. doi: 10.1158/1055-9965.EPI-13-0240

Figure 1.

Figure 1

Associations between EBNA1 seropositivity and risk of NHL subtypes (OR and 95% CI), with cases categorized by decreasing time interval between blood draw and diagnosis (circle: ≥8 years; triangle: 4-7 years; square: <4 years)